A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
Clinical trial NCT07286006 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07286006
- Sponsor
- Immunovant Sciences GmbH
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-26
- Primary completion
- 2030-03-01
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.